1 tracked superinvestor hold TREVI THERAPEUTICS INC (TRVI), worth $38M combined, led by Andreas Halvorsen. Smart money is holding TRVI as of the latest 13F filings.
Current price
$18.40
+178.3%
1Y
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic…
Market cap
$2.0B
P/E
-43.34
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$25
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$38M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
0
0 buying · 0 selling
Smart money is holding TRVI steady this quarter — buys and sells are balanced.
TREVI THERAPEUTICS INC (TRVI) is held by 1 tracked funds worth $38M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Andreas Halvorsen at 0.1% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
Tracked holders were largely static this quarter — no new opens, adds or trims of size — suggesting the position is being held rather than actively traded.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 0.1% | $38M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own TRVI?
1 tracked funds hold TREVI THERAPEUTICS INC (TRVI), the largest being Andreas Halvorsen (Viking Global Investors) at 0.1% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling TRVI?
In the most recent 13F quarter, 0 tracked funds added or opened TRVI and 0 trimmed it.
How much TRVI do tracked funds hold?
Combined disclosed long exposure to TRVI across tracked superinvestors is $38M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.